p62/sequestosome-1/A170/ZIP (hereafter referred to as p62) is a scaffold protein that has multiple functions, such as signal transduction, cell proliferation, cell survival, cell death, inflammation, tumourigenesis and oxidative stress response. While p62 is an autophagy substrate and is degraded by autophagy, p62 serves as an autophagy receptor for selective autophagic clearance of protein aggregates and organelles. Moreover, p62 functions as a signalling hub for various signalling pathways, including NF-κB, Nrf2 and mTOR. In this review, we discuss the pathophysiological role of p62 in the liver, including formation of hepatic inclusion bodies, cholestasis, obesity, insulin resistance, liver cell death and tumourigenesis.
MoscatJDiaz-MecoMT. p62 at the crossroads of autophagy, apoptosis, and cancer. Cell2009; 137: 1001–4.
2.
KomatsuMKageyamaSIchimuraY. p62/SQSTM1/A170: physiology and pathology. Pharmacol Res2012; 66: 457–62.
3.
IchimuraYKominamiETanakaKKomatsuM. Selective turnover of p62/A170/SQSTM1 by autophagy. Autophagy2008; 4: 1063–6.
4.
KomatsuMIchimuraY. Physiological significance of selective degradation of p62 by autophagy. FEBS Lett2010; 584: 1374–8.
5.
ShaidSBrandtsCHServeHDikicI. Ubiquitination and selective autophagy. Cell Death Differ2013; 20: 21–30.
6.
DuranASerranoMLeitgesMFloresJMPicardSBrownJPMoscatJDiaz-MecoMT. The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis. Dev Cell2004; 6: 303–9.
7.
MullerTDLeeSJJastrochMKabraDStemmerKAichlerMAbplanalpBAnanthakrishnanGBhardwajNCollinsSDivanovicSEndeleMFinanBGaoYHabeggerKMHembreeJHeppnerKMHofmannSHollandJKuchlerDKutschkeMKrishnaRLehtiMOelkrugROttawayNPerez-TilveDRaverCWalchAKSchrieverSCSpeakmanJTsengYHDiaz-MecoMPflugerPTMoscatJTschopMH. p62 links beta-adrenergic input to mitochondrial function and thermogenesis. J Clin Invest2013; 123: 469–78.
8.
GoodeALayfieldR. Recent advances in understanding the molecular basis of Paget disease of bone. J Clin Pathol2010; 63: 199–203.
MoscatJDiaz-MecoMT. Feedback on fat: p62-mTORC1-autophagy connections. Cell2011; 147: 724–7.
12.
ParkIChungJWalshCTYunYStromingerJLShinJ. Phosphotyrosine-independent binding of a 62-kDa protein to the src homology 2 (SH2) domain of p56lck and its regulation by phosphorylation of Ser-59 in the lck unique N-terminal region. Proc Natl Acad Sci U S A1995; 92: 12338–42.
13.
JoungIStromingerJLShinJ. Molecular cloning of a phosphotyrosine-independent ligand of the p56lck SH2 domain. Proc Natl Acad Sci U S A1996; 93: 5991–5.
14.
ShinJ. P62 and the sequestosome, a novel mechanism for protein metabolism. Arch Pharm Res1998; 21: 629–33.
15.
IshiiTYanagawaTKawaneTYukiKSeitaJYoshidaHBannaiS. Murine peritoneal macrophages induce a novel 60-kDa protein with structural similarity to a tyrosine kinase p56lck-associated protein in response to oxidative stress. Biochem Biophys Res Commun1996; 226: 456–60.
16.
SanchezPDe CarcerGSandovalIVMoscatJDiaz-MecoMT. Localization of atypical protein kinase C isoforms into lysosome-targeted endosomes through interaction with p62. Mol Cell Biol1998; 18: 3069–80.
17.
PulsASchmidtSGraweFStabelS. Interaction of protein kinase C zeta with ZIP, a novel protein kinase C-binding protein. Proc Natl Acad Sci U S A1997; 94: 6191–6.
18.
BjorkoyGLamarkTBrechAOutzenHPeranderMOvervatnAStenmarkHJohansenT. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol2005; 171: 603–14.
19.
IchimuraYKumanomidouTSouYSMizushimaTEzakiJUenoTKominamiEYamaneTTanakaKKomatsuM. Structural basis for sorting mechanism of p62 in selective autophagy. J Biol Chem2008; 283: 22847–57.
20.
PankivSClausenTHLamarkTBrechABruunJAOutzenHOvervatnABjorkoyGJohansenT. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem2007; 282: 24131–45.
21.
KomatsuMWaguriSKoikeMSouYSUenoTHaraTMizushimaNIwataJEzakiJMurataSHamazakiJNishitoYIemuraSNatsumeTYanagawaTUwayamaJWarabiEYoshidaHIshiiTKobayashiAYamamotoMYueZUchiyamaYKominamiETanakaK. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell2007; 131: 1149–63.
22.
StumptnerCHeidHFuchsbichlerAHauserHMischingerHJZatloukalKDenkH. Analysis of intracytoplasmic hyaline bodies in a hepatocellular carcinoma. Demonstration of p62 as major constituent. Am J Pathol1999; 154: 1701–10.
23.
ZatloukalKFrenchSWStumptnerCStrnadPHaradaMToivolaDMCadrinMOmaryMB. From Mallory to Mallory-Denk bodies: what, how and why?Exp Cell Res2007; 313: 2033–49.
24.
ZatloukalKStumptnerCFuchsbichlerAHeidHSchnoelzerMKennerLKleinertRPrinzMAguzziADenkH. p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases. Am J Pathol2002; 160: 255–63.
25.
SeibenhenerMLGeethaTWootenMW. Sequestosome 1/p62 – more than just a scaffold. FEBS Lett2007; 581: 175–9.
26.
KawaiKSaitoASudoTOsadaH. Specific regulation of cytokine-dependent p38 MAP kinase activation by p62/SQSTM1. J Biochem2008; 143: 765–72.
27.
SaitoAKawaiKTakayamaHSudoTOsadaH. Improvement of photoaffinity SPR imaging platform and determination of the binding site of p62/SQSTM1 to p38 MAP kinase. Chem Asian J2008; 3: 1607–12.
28.
PankivSLamarkTBruunJAOvervatnABjorkoyGJohansenT. Nucleocytoplasmic shuttling of p62/SQSTM1 and its role in recruitment of nuclear polyubiquitinated proteins to promyelocytic leukemia bodies. J Biol Chem2010; 285: 5941–53.
29.
SanzLDiaz-MecoMTNakanoHMoscatJ. The atypical PKC-interacting protein p62 channels NF-kappaB activation by the IL-1-TRAF6 pathway. EMBO J2000; 19: 1576–86.
30.
NezisIPStenmarkH. p62 at the interface of autophagy, oxidative stress signaling, and cancer. Antioxidants Redox Signal2012; 17: 786–93.
31.
MoscatJDiaz-MecoMTWootenMW. Of the atypical PKCs, Par-4 and p62: recent understandings of the biology and pathology of a PB1-dominated complex. Cell Death Diff2009; 16: 1426–37.
32.
ItakuraEMizushimaN. p62 Targeting to the autophagosome formation site requires self-oligomerization but not LC3 binding. J Cell Biol2011; 192: 17–27.
33.
SanzLSanchezPLallenaMJDiaz-MecoMTMoscatJ. The interaction of p62 with RIP links the atypical PKCs to NF-kappaB activation. EMBO J1999; 18: 3044–53.
34.
MoscatJDiaz-MecoMTWootenMW. Signal integration and diversification through the p62 scaffold protein. Trends Biochem Sci2007; 32: 95–100.
35.
JainALamarkTSjottemELarsenKBAwuhJAOvervatnAMcMahonMHayesJDJohansenT. p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J Biol Chem2010; 285: 22576–91.
36.
LauAWangXJZhaoFVilleneuveNFWuTJiangTSunZWhiteEZhangDD. A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62. Mol Cell Biol2010; 30: 3275–85.
37.
ZhangDD. Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab Rev2006; 38: 769–89.
38.
VadlamudiRKShinJ. Genomic structure and promoter analysis of the p62 gene encoding a non-proteasomal multiubiquitin chain binding protein. FEBS Lett1998; 435: 138–42.
39.
McManusSRouxS. The adaptor protein p62/SQSTM1 in osteoclast signaling pathways. J Mol Signal2012; 7: 1–1.
40.
LaurinNBrownJPMorissetteJRaymondV. Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. Am J Hum Genet2002; 70: 1582–8.
41.
HockingLJLucasGJDaroszewskaAMangionJOlavesenMCundyTNicholsonGCWardLBennettSTWuytsWVan HulWRalstonSH. Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease. Hum Mol Genet2002; 11: 2735–9.
42.
DuranALinaresJFGalvezASWikenheiserKFloresJMDiaz-MecoMTMoscatJ. The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis. Cancer Cell2008; 13: 343–54.
43.
WootenMWGeethaTSeibenhenerMLBabuJRDiaz-MecoMTMoscatJ. The p62 scaffold regulates nerve growth factor-induced NF-kappaB activation by influencing TRAF6 polyubiquitination. J Biol Chem2005; 280: 35625–9.
44.
ChamouxEMcManusSLabergeGBissonMRouxS. Involvement of kinase PKC-zeta in the p62/p62(P392L)-driven activation of NF-kappaB in human osteoclasts. Biochim Biophys Acta2013; 1832: 475–84.
45.
FujitaKMaedaDXiaoQSrinivasulaSM. Nrf2-mediated induction of p62 controls Toll-like receptor-4-driven aggresome-like induced structure formation and autophagic degradation. Proc Natl Acad Sci U S A2011; 108: 1427–32.
46.
WilliamsJAThomasAMLiGKongBZhanLInabaYXieWDingWXGuoGL. Tissue specific induction of p62/Sqstm1 by farnesoid X receptor. PloS one2012; 7: e43961–e43961.
47.
OkazakiMItoSKawakitaKTakeshitaSKawaiSMakishimaFOdaHKakinumaA. Cloning, expression profile, and genomic organization of the mouse STAP/A170 gene. Genomics1999; 60: 87–95.
48.
KuusistoESuuronenTSalminenA. Ubiquitin-binding protein p62 expression is induced during apoptosis and proteasomal inhibition in neuronal cells. Biochem Biophys Res Commun2001; 280: 223–8.
49.
IshiiTYanagawaTYukiKKawaneTYoshidaHBannaiS. Low micromolar levels of hydrogen peroxide and proteasome inhibitors induce the 60-kDa A170 stress protein in murine peritoneal macrophages. Biochem Biophys Res Commun1997; 232: 33–7.
50.
PuissantARobertGFenouilleNLucianoFCassutoJPRaynaudSAubergerP. Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation. Cancer Res2010; 70: 1042–52.
51.
MatsumotoGWadaKOkunoMKurosawaMNukinaN. Serine 403 phosphorylation of p62/SQSTM1 regulates selective autophagic clearance of ubiquitinated proteins. Mol Cell2011; 44: 279–89.
NiHMBoggessNMcGillMRLebofskyMBorudePApteUJaeschkeHDingWX. Liver-specific loss of Atg5 causes persistent activation of Nrf2 and protects against acetaminophen-induced liver injury. Toxicol Sci2012; 127: 438–50.
54.
SeibenhenerMLBabuJRGeethaTWongHCKrishnaNRWootenMW. Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation. Mol Cell Biol2004; 24: 8055–68.
55.
DingWXGuoFNiHMBockusAManleySStolzDBEskelinenELJaeschkeHYinXM. Parkin and mitofusins reciprocally regulate mitophagy and mitochondrial spheroid formation. J Biol Chem2012; 287: 42379–88.
56.
KimPKHaileyDWMullenRTLippincott-SchwartzJ. Ubiquitin signals autophagic degradation of cytosolic proteins and peroxisomes. Proc Natl Acad Sci U S A2008; 105: 20567–74.
57.
PonpuakMDavisASRobertsEADelgadoMADinkinsCZhaoZVirginHWtKyeiGBJohansenTVergneIDereticV. Delivery of cytosolic components by autophagic adaptor protein p62 endows autophagosomes with unique antimicrobial properties. Immunity2010; 32: 329–41.
58.
FilimonenkoMIsaksonPFinleyKDAndersonMJeongHMeliaTJBartlettBJMyersKMBirkelandHCLamarkTKraincDBrechAStenmarkHSimonsenAYamamotoA. The selective macroautophagic degradation of aggregated proteins requires the PI3P-binding protein Alfy. Mol Cell2010; 38: 265–79.
59.
KirkinVLamarkTSouYSBjorkoyGNunnJLBruunJAShvetsEMcEwanDGClausenTHWildPBilusicITheurillatJPOvervatnAIshiiTElazarZKomatsuMDikicIJohansenT. A role for NBR1 in autophagosomal degradation of ubiquitinated substrates. Mol Cell2009; 33: 505–16.
60.
SimonsenABirkelandHCGilloolyDJMizushimaNKumaAYoshimoriTSlagsvoldTBrechAStenmarkH. Alfy, a novel FYVE-domain-containing protein associated with protein granules and autophagic membranes. J Cell Sci2004; 117: 4239–51.
61.
ClausenTHLamarkTIsaksonPFinleyKLarsenKBBrechAOvervatnAStenmarkHBjorkoyGSimonsenAJohansenT. p62/SQSTM1 and ALFY interact to facilitate the formation of p62 bodies/ALIS and their degradation by autophagy. Autophagy2010; 6: 330–44.
62.
IwataARileyBEJohnstonJAKopitoRR. HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin. J Biol Chem2005; 280: 40282–92.
YaoTP. The role of ubiquitin in autophagy-dependent protein aggregate processing. Genes Cancer2010; 1: 779–86.
65.
DingWXYinXM. Sorting, recognition and activation of the misfolded protein degradation pathways through macroautophagy and the proteasome. Autophagy2008; 4: 141–50.
66.
DingWXNiHMLiMLiaoYChenXStolzDBDornGW2ndYinXM. Nix is critical to two distinct phases of mitophagy, reactive oxygen species-mediated autophagy induction and Parkin-ubiquitin-p62-mediated mitochondrial priming. J Biol Chem2010; 285: 27879–90.
67.
GeislerSHolmstromKMSkujatDFieselFCRothfussOCKahlePJSpringerW. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol2010; 12: 119–31.
68.
PohlCJentschS. Midbody ring disposal by autophagy is a post-abscission event of cytokinesis. Nat Cell Biol2009; 11: 65–70.
69.
CemmaMKimPKBrumellJH. The ubiquitin-binding adaptor proteins p62/SQSTM1 and NDP52 are recruited independently to bacteria-associated microdomains to target Salmonella to the autophagy pathway. Autophagy2011; 7: 341–5.
70.
NarendraDTanakaASuenDFYouleRJ. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol2008; 183: 795–803.
71.
NarendraDPJinSMTanakaASuenDFGautierCAShenJCooksonMRYouleRJ. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol2010; 8: e1000298–e1000298.
72.
Vives-BauzaCZhouCHuangYCuiMde VriesRLKimJMayJTocilescuMALiuWKoHSMagraneJMooreDJDawsonVLGrailheRDawsonTMLiCTieuKPrzedborskiS. PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc Natl Acad Sci U S A2010; 107: 378–83.
73.
JinSMLazarouMWangCKaneLANarendraDPYouleRJ. Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL. J Cell Biol2010; 191: 933–42.
74.
LazarouMNarendraDPJinSMTekleEBanerjeeSYouleRJ. PINK1 drives Parkin self-association and HECT-like E3 activity upstream of mitochondrial binding. J Cell Biol2013; 200: 163–72.
75.
Shiba-FukushimaKImaiYYoshidaSIshihamaYKanaoTSatoSHattoriN. PINK1-mediated phosphorylation of the Parkin ubiquitin-like domain primes mitochondrial translocation of Parkin and regulates mitophagy. Sci Rep2012; 2: 1002–1002.
76.
ChanNCSalazarAMPhamAHSweredoskiMJKolawaNJGrahamRLHessSChanDC. Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy. Hum Mol Genet2011; 20: 1726–37.
77.
YoshiiSRKishiCIshiharaNMizushimaN. Parkin mediates proteasome-dependent protein degradation and rupture of the outer mitochondrial membrane. J Biol Chem2011; 286: 19630–40.
78.
NarendraDKaneLAHauserDNFearnleyIMYouleRJ. p62/SQSTM1 is required for Parkin-induced mitochondrial clustering but not mitophagy; VDAC1 is dispensable for both. Autophagy2010; 6: 1090–106.
79.
StumptnerCFuchsbichlerAZatloukalKDenkH. In vitro production of Mallory bodies and intracellular hyaline bodies: the central role of sequestosome 1/p62. Hepatology2007; 46: 851–60.
HaradaMHanadaSToivolaDMGhoriNOmaryMB. Autophagy activation by rapamycin eliminates mouse Mallory-Denk bodies and blocks their proteasome inhibitor-mediated formation. Hepatology2008; 47: 2026–35.
84.
KawaguchiYKovacsJJMcLaurinAVanceJMItoAYaoTP. The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell2003; 115: 727–38.
85.
KomatsuMKurokawaHWaguriSTaguchiKKobayashiAIchimuraYSouYSUenoISakamotoATongKIKimMNishitoYIemuraSNatsumeTUenoTKominamiEMotohashiHTanakaKYamamotoM. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol2010; 12: 213–23.
86.
SasakiMMiyakoshiMSatoYNakanumaY. A possible involvement of p62/sequestosome-1 in the process of biliary epithelial autophagy and senescence in primary biliary cirrhosis. Liver Int2012; 32: 487–99.
87.
SasakiMMiyakoshiMSatoYNakanumaY. Autophagy may precede cellular senescence of bile ductular cells in ductular reaction in primary biliary cirrhosis. Dig Dis Sci2012; 57: 660–6.
88.
FickertPTraunerMFuchsbichlerAStumptnerCZatloukalKDenkH. Bile acid-induced Mallory body formation in drug-primed mouse liver. Am J Pathol2002; 161: 2019–26.
89.
GerberMAOrrWDenkHSchaffnerFPopperH. Hepatocellular hyalin in cholestasis and cirrhosis: its diagnostic significance. Gastroenterology1973; 64: 89–98.
90.
YokooHCraigRMHarwoodTRCochraneC. Griseofulvin-induced cholestasis in Swiss albino mice. Gastroenterology1979; 77: 1082–7.
91.
MeermanLKoopenNRBloksVVan GoorHHavingaRWolthersBGKramerWStengelinSMullerMKuipersFJansenPL. Biliary fibrosis associated with altered bile composition in a mouse model of erythropoietic protoporphyria. Gastroenterology1999; 117: 696–705.
92.
NguyenDMEl-SeragHB. The epidemiology of obesity. Gastroenterology Clin North Am2010; 39: 1–7.
93.
CaldwellSHCrespoDMKangHSAl-OsaimiAM. Obesity and hepatocellular carcinoma. Gastroenterology2004; 127: S97–103.
94.
RodriguezADuranASelloumMChampyMFDiez-GuerraFJFloresJMSerranoMAuwerxJDiaz-MecoMTMoscatJ. Mature-onset obesity and insulin resistance in mice deficient in the signaling adapter p62. Cell Metab2006; 3: 211–22.
95.
BostFAouadiMCaronLEvenPBelmonteNProtMDaniCHofmanPPagesGPouyssegurJLe Marchand-BrustelYBinetruyB. The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis. Diabetes2005; 54: 402–11.
96.
BostFAouadiMCaronLBinetruyB. The role of MAPKs in adipocyte differentiation and obesity. Biochimie2005; 87: 51–6.
97.
LeeSJPflugerPTKimJYNogueirasRDuranAPagesGPouyssegurJTschopMHDiaz-MecoMTMoscatJ. A functional role for the p62-ERK1 axis in the control of energy homeostasis and adipogenesis. EMBO Rep2010; 11: 226–32.
98.
MullerTDLeeSJJastrochMKabraDStemmerKAichlerMAbplanalpBAnanthakrishnanGBhardwajNCollinsSDivanovicSEndeleMFinanBGaoYHabeggerKMHembreeJHeppnerKMHofmannSHollandJKuchlerDKutschkeMKrishnaRLehtiMOelkrugROttawayNPerez-TilveDRaverCWalchAKSchrieverSCSpeakmanJTsengYHDiaz-MecoMPflugerPTMoscatJTschopMH. p62 Links beta-adrenergic input to mitochondrial function and thermogenesis. J Clin Investig2013; 123: 469–78.
99.
HirosumiJTuncmanGChangLGorgunCZUysalKTMaedaKKarinMHotamisligilGS. A central role for JNK in obesity and insulin resistance. Nature2002; 420: 333–6.
100.
SolinasGNauglerWGalimiFLeeMSKarinM. Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates. Proc Natl Acad Sci USA2006; 103: 16454–9.
101.
SekiEBrennerDAKarinM. A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches. Gastroenterology2012; 143: 307–20.
102.
SinghRWangYXiangYTanakaKEGaardeWACzajaMJ. Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance. Hepatology2009; 49: 87–96.
103.
DingWXNiHMGaoWYoshimoriTStolzDBRonDYinXM. Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability. Am J Pathol2007; 171: 513–24.
LiDDWangLLDengRTangJShenYGuoJFWangYXiaLPFengGKLiuQQHuangWLZengYXZhuXF. The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents-induced autophagy in cancer cells. Oncogene2009; 28: 886–98.
106.
GeethaTZhengCVishwaprakashNBroderickTLBabuJR. Sequestosome 1/p62, a scaffolding protein, is a newly identified partner of IRS-1 protein. J Biol Chem2012; 287: 29672–8.
107.
InamiYWaguriSSakamotoAKounoTNakadaKHinoOWatanabeSAndoJIwadateMYamamotoMLeeMSTanakaKKomatsuM. Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells. J Cell Biol2011; 193: 275–84.
108.
ThompsonHGHarrisJWWoldBJLinFBrodyJP. p62 overexpression in breast tumors and regulation by prostate-derived Ets factor in breast cancer cells. Oncogene2003; 22: 2322–33.
109.
InoueDSuzukiTMitsuishiYMikiYSuzukiSSugawaraSWatanabeMSakuradaAEndoCUrunoASasanoHNakagawaTSatohKTanakaNKuboHMotohashiHYamamotoM. Accumulation of p62/SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma. Cancer Sci2012; 103: 760–6.
110.
Myung ParkJHuangSWuTTFosterNRSinicropeFA. Prognostic impact of Beclin 1, p62/sequestosome 1 and LC3 protein expression in colon carcinomas from patients receiving 5-fluorouracil as adjuvant chemotherapy. Cancer Biol Ther2013; 14: 100–7.
111.
MoscatJDiaz-MecoMT. p62: a versatile multitasker takes on cancer. Trends Biochem Sci2012; 37: 230–6.
112.
NakamuraKKimpleAJSiderovskiDPJohnsonGL. PB1 domain interaction of p62/sequestosome 1 and MEKK3 regulates NF-kappaB activation. J Biol Chem2010; 285: 2077–89.
113.
JinWChangMPaulEMBabuGLeeAJReileyWWrightAZhangMYouJSunSC. Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice. J Clin Invest2008; 118: 1858–66.
114.
HeGKarinM. NF-kappaB and STAT3 – key players in liver inflammation and cancer. Cell Res2011; 21: 159–68.
115.
PikarskyEPoratRMSteinIAbramovitchRAmitSKasemSGutkovich-PyestEUrieli-ShovalSGalunEBen-NeriahY. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature2004; 431: 461–6.
116.
MaedaSKamataHLuoJLLeffertHKarinM. IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell2005; 121: 977–90.
117.
LueddeTBerazaNKotsikorisVVan LooGNenciADe VosRRoskamsTTrautweinCPasparakisM. Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. Cancer Cell2007; 11: 119–32.
118.
MathewRKarpCMBeaudoinBVuongNChenGChenHYBrayKReddyABhanotGGelinasCDipaolaRSKarantza-WadsworthVWhiteE. Autophagy suppresses tumorigenesis through elimination of p62. Cell2009; 137: 1062–75.
119.
WangXJSunZVilleneuveNFZhangSZhaoFLiYChenWYiXZhengWWondrakGTWongPKZhangDD. Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis2008; 29: 1235–43.
120.
KwakMKItohKYamamotoMSutterTRKenslerTW. Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1, 2-dimethiole-3-thione. Mol Med2001; 7: 135–45.
121.
DuYVilleneuveNFWangXJSunZChenWLiJLouHWongPKZhangDD. Oridonin confers protection against arsenic-induced toxicity through activation of the Nrf2-mediated defensive response. Environ Health Perspect2008; 116: 1154–61.
122.
TaguchiKFujikawaNKomatsuMIshiiTUnnoMAkaikeTMotohashiHYamamotoM. Keap1 degradation by autophagy for the maintenance of redox homeostasis. Proc Natl Acad Sci U S A2012; 109: 13561–6.
123.
JinZLiYPittiRLawrenceDPhamVCLillJRAshkenaziA. Cullin3-based polyubiquitination and p62-dependent aggregation of caspase-8 mediate extrinsic apoptosis signaling. Cell2009; 137: 721–35.
124.
PanJAUllmanEDouZZongWX. Inhibition of protein degradation induces apoptosis through a microtubule-associated protein 1 light chain 3-mediated activation of caspase-8 at intracellular membranes. Mol Cell Biol2011; 31: 3158–70.
125.
UllmanEPanJAZongWX. Squamous cell carcinoma antigen 1 promotes caspase-8-mediated apoptosis in response to endoplasmic reticulum stress while inhibiting necrosis induced by lysosomal injury. Mol Cell Biol2011; 31: 2902–19.
126.
YoungMMTakahashiYKhanOParkSHoriTYunJSharmaAKAminSHuCDZhangJKesterMWangHG. Autophagosomal membrane serves as platform for intracellular death-inducing signaling complex (iDISC)-mediated caspase-8 activation and apoptosis. J Biol Chem2012; 287: 12455–68.
127.
RileyBEKaiserSEShalerTANgACHaraTHippMSLageKXavierRJRyuKYTaguchiKYamamotoMTanakaKMizushimaNKomatsuMKopitoRR. Ubiquitin accumulation in autophagy-deficient mice is dependent on the Nrf2-mediated stress response pathway: a potential role for protein aggregation in autophagic substrate selection. J Cell Biol2010; 191: 537–52.
128.
BaeSHSungSHOhSYLimJMLeeSKParkYNLeeHEKangDRheeSG. Sestrins activate Nrf2 by promoting p62-dependent autophagic degradation of Keap1 and prevent oxidative liver damage. Cell Metab2013; 17: 73–84.
NiHMBockusABoggessNJaeschkeHDingWX. Activation of autophagy protects against acetaminophen-induced hepatotoxicity. Hepatology2012; 55: 222–32.
131.
LauAVilleneuveNFSunZWongPKZhangDD. Dual roles of Nrf2 in cancer. Pharmacol Res2008; 58: 262–70.
132.
Ramos-GomezMKwakMKDolanPMItohKYamamotoMTalalayPKenslerTW. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc Natl Acad Sci USA2001; 98: 3410–5.
133.
IidaKItohKKumagaiYOyasuRHattoriKKawaiKShimazuiTAkazaHYamamotoM. Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis. Cancer Res2004; 64: 6424–31.
134.
HayesJDMcMahonM. NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer. Trends Biochem Sci2009; 34: 176–88.
135.
TaguchiKMotohashiHYamamotoM. Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells2011; 16: 123–40.
RubinszteinDCGestwickiJEMurphyLOKlionskyDJ. Potential therapeutic applications of autophagy. Nat Rev Drug Discov2007; 6: 304–12.
138.
BlommaartEFLuikenJJBlommaartPJvan WoerkomGMMeijerAJ. Phosphorylation of ribosomal protein S6 is inhibitory for autophagy in isolated rat hepatocytes. J Biol Chem1995; 270: 2320–6.
139.
MizushimaN. The role of the Atg1/ULK1 complex in autophagy regulation. Curr Opin Cell Biol2010; 22: 132–9.
140.
GurusamyNLekliIMukherjeeSRayDAhsanMKGherghiceanuMPopescuLMDasDK. Cardioprotection by resveratrol: a novel mechanism via autophagy involving the mTORC2 pathway. Cardiovasc Res2010; 86: 103–12.
141.
MammucariCMilanGRomanelloVMasieroERudolfRDelPiccoloPBurdenSJDiLisiRSandriCZhaoJGoldbergALSchiaffinoSSandriM. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab2007; 6: 458–71.
142.
EfeyanAZoncuRSabatiniDM. Amino acids and mTORC1: from lysosomes to disease. Trends Mol Med2012; 18: 524–33.
143.
LaplanteMSabatiniDM. mTOR signaling in growth control and disease. Cell2012; 149: 274–93.
144.
ZoncuREfeyanASabatiniDM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol2011; 12: 21–35.
145.
LaplanteMSabatiniDM. An emerging role of mTOR in lipid biosynthesis. Curr Biol2009; 19: R1046–52.
146.
RicoultSJManningBD. The multifaceted role of mTORC1 in the control of lipid metabolism. EMBO Rep2013; 14: 242–51.
147.
SancakYBar-PeledLZoncuRMarkhardALNadaSSabatiniDM. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell2010; 141: 290–303.
148.
YuLMcPheeCKZhengLMardonesGARongYPengJMiNZhaoYLiuZWanFHaileyDWOorschotVKlumpermanJBaehreckeEHLenardoMJ. Termination of autophagy and reformation of lysosomes regulated by mTOR. Nature2010; 465: 942–6.
149.
DuranAAmanchyRLinaresJFJoshiJAbu-BakerSPorolloAHansenMMoscatJDiaz-MecoMT. p62 is a key regulator of nutrient sensing in the mTORC1 pathway. Mol Cell2011; 44: 134–46.
150.
MenonSYeciesJLZhangHHHowellJJNicholatosJHarputlugilEBronsonRTKwiatkowskiDJManningBD. Chronic activation of mTOR complex 1 is sufficient to cause hepatocellular carcinoma in mice. Sci Signal2012; 5: ra24.–ra24..
